Pre-clinical characterization of PKC412, a multi-kinase inhibitor, against colorectal cancer cells

The potential effect of PKC412, a small molecular multi-kinase inhibitor, in colorectal cancer (CRC) cells was evaluated here. We showed that PKC412 was cytotoxic and anti-proliferative against CRC cell lines (HT-29, HCT-116, HT-15 and DLD-1) and primary CRC cells. PKC412 provoked caspase-dependent...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian-Ping, Huang, Zhi-Jun, Lu, Xing-Sheng, Zhou, Yi-Chan, Shao, Yun, He, Xiao-Pu, Chen, Su-Rong, Wang, Dong-Dong, Qin, Li-Sen, Sun, Wei-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363623/
https://www.ncbi.nlm.nih.gov/pubmed/27780925
http://dx.doi.org/10.18632/oncotarget.12802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363623/
https://www.ncbi.nlm.nih.gov/pubmed/27780925
http://dx.doi.org/10.18632/oncotarget.12802

Ejemplares similares